1
/
of
0
FDA Drug Approval, N17884, CHRONULAC
FDA Drug Approval, N17884, CHRONULAC
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 17884
Company: SANOFI AVENTIS US
Drug Name: CHRONULAC
Active Ingredients: LACTULOSE
Strength: 10GM/15ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: SOLUTION;ORAL
Action Date: 01/00/1900
Marketing Status: Discontinued
Submission Classification:
Company: SANOFI AVENTIS US
Drug Name: CHRONULAC
Active Ingredients: LACTULOSE
Strength: 10GM/15ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: SOLUTION;ORAL
Action Date: 01/00/1900
Marketing Status: Discontinued
Submission Classification:
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details